NCT04368156View on ClinicalTrials.gov

Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 20, 2020

Primary Completion Date

February 17, 2021

Study Completion Date

February 17, 2021

Conditions
Covid-19
Interventions
DEVICE

gammaCore® (Vagus nerve stimulation)

Vagus nerve stimulation using the gammacore neurostimulation device

Trial Locations (1)

46010

Hospital Clínico Universitario de Valencia, Valencia

All Listed Sponsors
lead

Carlos Tornero

OTHER

NCT04368156 - Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms | Biotech Hunter | Biotech Hunter